Patent · US Active

Kits containing DLL3 antibody drug conjugates

US9861708B2 · kind B2 · utility

7Cited by
47References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 7, 2017
Grant dateJan 9, 2018
Priority date—
Expiry dateJun 7, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70596
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.